Your browser doesn't support javascript.
loading
Further insights into cortactin conformational regulation.
Evans, Jason V; Kelley, Laura C; Hayes, Karen E; Ammer, Amanda Gatesman; Martin, Karen H; Weed, Scott A.
Afiliación
  • Evans JV; Department of Neurobiology and Anatomy; Program in Cancer Cell Biology; Mary Babb Randolph Cancer Center; West Virginia University; Morgantown, WV USA.
Bioarchitecture ; 1(1): 21-23, 2011 Jan.
Article en En | MEDLINE | ID: mdl-21866257
ABSTRACT
The actin regulatory protein cortactin is involved in multiple signaling pathways impinging on the cortical actin cytoskeleton. Cortactin is phosphorylated by ERK1/2 and Src family tyrosine kinases, resulting in neuronal Wiskott Aldrich Syndrome protein (N-WASp) activation and enhanced actin related protein (Arp)2/3-mediated actin nucleation. Cortactin migrates as an 80/85 kDa doublet when analyzed by SDS-PAGE. Phosphorylation by ERK1/2 is associated with conversion of the 80 kDa to the 85 kDa form, postulated to occur by inducing a conformational alteration that releases the carboxyl-terminal SH3 domain from autoinhibition. Our recent analysis of the 80-85 kDa cortactin "shift" in tumor cells indicates that while ERK1/2 phosphorylation is associated with the 85 kDa shift, this phosphorylation event is not required for the shift to occur, nor does ERK1/2 phosphorylation appreciably alter global cortactin confirmation. These data indicate that additional factors besides ERK1/2 phosphorylation contribute to generating and/or maintaining the activated 85 kDa cortactin form in stimulated cells.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Bioarchitecture Año: 2011 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Bioarchitecture Año: 2011 Tipo del documento: Article